Researchers Target Brain Circuits for Addiction, Relapse

FDA grants priority review for Alkermes’ VIVITROL sNDA for opioid dependence
Alkermes, Inc. today announced that the supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence has been designated a priority review by the U.S. Food and Drug Administration (FDA).

Read more on News-Medical-Net

A beacon of hope for victims of domestic abuse
For the past nine years, the James House has served as Hopewell’s beacon of hope for victims of sexual and domestic abuse. Every year, volunteers and professionals at the outreach center on Maplewood Avenue help more than a thousand clients, who seek su

Read more on The Petersburg Progress-Index

Researchers target brain circuits for addiction, relapse
WASHINGTON — Could a once-a-month alcoholism shot keep some of the highest-risk heroin addicts from relapse? A drug that wakes up narcoleptics treat cocaine addiction?

Read more on Contra Costa Times

Related Drug Addiction Blogs

Subscribe to Our Feed!

Enter your email address:

Delivered by FeedBurner